1-10 of 10
Hanna Jean Khoury, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results from REACH1, a Single-Arm Phase 2 Study of Ruxolitinib in Combination with Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Vs-Host Disease

Madan Jagasia, MD MS, Miguel-Angel Perales, MD, Mark A Schroeder, MD, Haris Ali, MD, Nirav N Shah, MD, Yi-Bin Chen, MD, Michael C. Arbushites, Fitzroy Dawkins, MD, Chuan Tian, PhD, Hanna Jean Khoury, MD FACP
Journal: Blood
Blood (2018) 132 (Supplement 1): 601.
https://doi.org/10.1182/blood-2018-99-116342
Published: 2018
Journal Articles

A Multi-Center Prospective Study Utilizing a Simplified Treatment Algorithm Complemented By Expert Support Decreases Induction Mortality and Improves Survival in Acute Promyelocytic Leukemia (APL). Results of the APL Trial in Georgia, South Carolina and Neighboring States

Anand Jillella, MD, Prachi Karkhanis, Rashmi Sharma, Sheldon Bolds, Anima Shrestha, Kaitlin Sitchenko, Veeraen Jonnalagadda, Manila Gaddh, MD, Leon Bernal-Mizrachi, MD, Leonard T. Heffner, MD, Elliott F. Winton, MD, Morgan L. McLemore, MD, Amelia Langston, MD, Jacques Galipeau, MD, Imre Bodó, MD PhD, Zaid Al-Kadhimi, MD, Asad Bashey, MD PhD, Robert K. Stuart, MD, Sarah I. Vidito, DO, Asim Pati, MD, Jonathan M. Gerber, MD, Michael R. Grunwald, MD, Kyle T. Bradley, MD MS, Jose Tongol, MD, Mohamed El-Geneidy, Hanna Jean Khoury, MD, Martha Arellano, MD, Vamsi Kota, MD
Journal: Blood
Blood (2016) 128 (22): 2793.
https://doi.org/10.1182/blood.V128.22.2793.2793
Published: 2016
Journal Articles

Outcomes of Chronic Phase Chronic Myeloid Leukemia Patients Following Tyrosine Kinase Inhibitors Dose-Reductions

Jee Hyun Kong, MD, Hanna Jean Khoury, MD, Elliott F. Winton, MD, Leonard T. Heffner, MD, Manila Gaddh, MD, Martha Arellano, MD, Fuad El-Rassi, MD, Audrey S Kim, RN, Anand Jillella, MD, Imre Bodó, MDPhD, Vamsi Kota, MD
Journal: Blood
Blood (2016) 128 (22): 3093.
https://doi.org/10.1182/blood.V128.22.3093.3093
Published: 2016
Journal Articles

A Prospective Multi-Center Trial Shows Reduction of Early Deaths (ED) and Improved Survival in Elderly Acute Promyelocytic Leukemia (APL) Patients (>60 years). Results of Using a Simplified Treatment Algorithm and Expert Support in Georgia, South Carolina and Neighboring States

Vamsi Kota, MD, Prachi Karkhanis, Rashmi Sharma, Sheldon Bolds, Kaitlin Sitchenko, Anima Shrestha, Veeraen Jonnalagadda, Manila Gaddh, MD, Leon Bernal-Mizrachi, MD, Leonard T. Heffner, MD, Elliott F. Winton, MD, Morgan L. McLemore, MD, Amelia Langston, MD, Jacques Galipeau, MD, Imre Bodó, MD PhD, Zaid Al-Kadhimi, MD, Asad Bashey, MD PhD, Robert K. Stuart, MD, Sarah I. Vidito, DO, Asim Pati, MD, Jonathan M. Gerber, MD, Michael R. Grunwald, MD, Kyle T. Bradley, MD MS, Jose Tongol, MD, Mohamed El-Geneidy, Hanna Jean Khoury, MD, Martha Arellano, MD, Anand Jillella, MD
Journal: Blood
Blood (2016) 128 (22): 1622.
https://doi.org/10.1182/blood.V128.22.1622.1622
Published: 2016
Journal Articles

Outcomes of Grades II-IV Acute Graft-Versus-Host Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation: How Much Progress Was Achieved?

Hanna Jean Khoury, MD, Tao Wang, PhD, Mukta Arora, MD, Michael Hemmer, MS, Stephen R. Spellman, MBS, Corey S Cutler, MD MPH, Daniel R. Couriel, MD, Amin M. Alousi, MD, Joseph A. Joseph, MD
Journal: Blood
Blood (2015) 126 (23): 3132.
https://doi.org/10.1182/blood.V126.23.3132.3132
Published: 2015
Journal Articles

Temperature and Humidity Effects on Acute Vaso-Occlusive Pain Episodes in Sickle Cell Disease

Fuad El Rassi, MD, Eldrida Randall, MS, Sidney F. Stein, MD, Hanna Jean Khoury, MD, James R. Eckman, MD, Morgan L. McLemore, MD
Journal: Blood
Blood (2015) 126 (23): 992.
https://doi.org/10.1182/blood.V126.23.992.992
Published: 2015
Journal Articles

Outcomes of Allogeneic Transplantation in Patients Aged ≤ 60 Years with Acute Myeloid Leukemia in Second Complete Remission: A CIBMTR ® Cohort Analysis

Fotios V. Michelis, MDPhD, Vikas Gupta, MD FRCP, FRCPath, Mei-Jie Zhang, PhD, Hai-Lin Wang, MPH, Marcos de Lima, MD, Hanna Jean Khoury, MD, Brenda M Sandmaier, MD, Wael Saber, MD MS
Journal: Blood
Blood (2015) 126 (23): 2009.
https://doi.org/10.1182/blood.V126.23.2009.2009
Published: 2015
Journal Articles

Dasatinib Is Well-Tolerated and Efficacious in Imatinib-Intolerant Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML).

Hanna Jean Khoury, MD, Michael J. Mauro, MD, Yousif Matloub, MD, Tai-Tsang Chen, PhD, Erkut Bahceci, MD, Michael Deininger, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1128.
https://doi.org/10.1182/blood.V114.22.1128.1128
Published: 2009
Journal Articles

Nilotinib Responses and Tolerability Confirmed in North American Patients with Chronic Myeloid Leukemia (CML) From ENACT (Expanding Nilotinib Access in Clinical Trials).

Bayard L. Powell, MD, Hanna Jean Khoury, MD, Jeffrey H. Lipton, David A. Rizzieri, Denise Williams, MD, A. Robert Turner, MD, FRCPC
Journal: Blood
Blood (2009) 114 (22): 3295.
https://doi.org/10.1182/blood.V114.22.3295.3295
Published: 2009
Journal Articles

Targeting 14-3-3 Sensitizes Native and Mutant BCR-ABL to Inhibition with U0126, Rapamycin and Bcl-2 Inhibitor GX15-070.

Shaozhong Dong, PhD, Sumin Kang, PhD, Sagar Lonial, MD, Hanna Jean Khoury, MD, Jean Viallet, PhD, Jing Chen, PhD
Journal: Blood
Blood (2007) 110 (11): 2920.
https://doi.org/10.1182/blood.V110.11.2920.2920
Published: 2007